LifeMD Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for LifeMD, Inc. (LFMD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-18.88-17.84-45.54-61.32-58.65
Depreciation & Amortization1.476.931.092.960.34
Deferred Income Tax0.000.000.350.00-0.07
Stock Based Compensation12.2312.4913.7312.0736.96
Change in Working Capital12.655.72-1.559.138.87
Change in Accounts Receivable-2.94-2.44-2.190.02-0.82
Change in Inventory-0.710.41-2.18-0.41-0.31
Change in Accounts Payable4.920.981.25-0.899.76
Change in Other Working Capital5.721.80-2.479.84-0.57
Other Operating Activities1.6213.68-2.2216.15-1.03
Net Cash from Operating Activities17.518.82-22.94-33.09-12.13
Investing Activities
Capital Expenditures-1.498.73-0.373.400.40
Acquisitions0.000.00-1.010.00-0.40
Sales/Maturities of Investments-10.05-8.53-12.53-3.15-0.40
Other Investing Activities-10.050.000.000.000.00
Net Cash from Investing Activities-11.54-8.73-13.91-3.40-0.80
Financing Activities
Debt Repayment-0.33-5.14-0.17-16.49-2.50
Common Stock Issued0.1210.000.1313.9918.16
Dividends Paid-3.113.11-3.110.870.00
Other Financing Activities-0.815.44-0.2954.90-0.15
Net Cash from Financing Activities-4.1229.10-0.5368.6421.00
Summary
Net Change in Cash1.8629.19-37.3732.158.07
Cash at Beginning of Period33.153.9641.339.181.11
Cash at End of Period35.0029.193.9641.339.18
Free Cash Flow16.028.47-23.30-33.36-12.13
Supplemental Disclosures
Interest Paid2.532.150.190.441.67